tetrahydrocurcumin has been researched along with Alzheimer Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, Y; Geng, F; Li, L; Wang, J; Wang, S; Xiao, Y; Xu, Y; Zhao, J | 1 |
1 other study(ies) available for tetrahydrocurcumin and Alzheimer Disease
| Article | Year |
|---|---|
Tetrahydrocurcumin ameliorates Alzheimer's pathological phenotypes by inhibition of microglial cell cycle arrest and apoptosis via Ras/ERK signaling.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Apoptosis; Cell Cycle Checkpoints; Cell Line; Curcumin; Cyclin D2; Disease Models, Animal; Down-Regulation; Hippocampus; Humans; MAP Kinase Signaling System; Maze Learning; Memory; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microglia; Proteomics; ras Proteins; Signal Transduction; Up-Regulation | 2021 |